MD Anderson partners with Bellicum for cell therapy safety innovation.
TL;DR: MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals. The acquisition includes CaspaCIDe switch platform, GoCAR platform, and clinical-grade stocks of rimiducid. The University of Texas MD Anderson…